4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #medications #table ... #comparison #management
Dilated Common Bile Duct on POCUS
50's yo patient with RUQ abd pain. Vitals stable/afebrile. Labs: WBC
Common Bile Duct on POCUS ... Vitals stable/afebrile ... mass in distal CBD ... RJonesSonoEM #Dilated #CBD ... #clinical #biliary
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... factors: Age>60, CKD ... hematology #diagnosis #comparison ... #table